Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
6.345 USD | +1.68% | +1.44% | -1.55% |
Kurzporträt
Mitarbeiterzahl: 467
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Chimeric Antigen Receptors T Cell Therapies
100,0
%
| 6 | 100,0 % | 2 | 100,0 % | -73.30% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
79,6
%
| - | - | 1 | 79,6 % | - |
United Kingdom
20,4
%
| - | - | 0 | 20,4 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 01.09.14 |
Chief Executive Officer | 59 | 01.10.14 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 07.08.23 |
Chief Tech/Sci/R&D Officer | - | 01.04.23 | |
David Brochu
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.19 |
Christopher Vann
COO | Chief Operating Officer | 59 | 01.10.16 |
Julia Wilson
IRC | Investor Relations Contact | - | - |
Alexander Swan
IRO | Public Communications Contact | - | 01.10.21 |
Olivia Manser
IRO | Public Communications Contact | - | 01.03.22 |
Miranda Neville
PRN | Corporate Officer/Principal | - | 01.01.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 01.08.14 |
William Young
BRD | Director/Board Member | 79 | 15.11.21 |
John Johnson
CHM | Chairman | 66 | 15.09.21 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01.03.18 |
Martin Murphy
BRD | Director/Board Member | 55 | 01.09.14 |
Chief Executive Officer | 59 | 01.10.14 | |
Linda Bain
BRD | Director/Board Member | 53 | 08.06.18 |
Robert Iannone
BRD | Director/Board Member | 57 | 20.06.23 |
Martin Pulé
FOU | Founder | 51 | 01.09.14 |
Director/Board Member | 47 | 20.12. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 265 926 305 | 8 823 530 ( 3,318 %) | 0 | 3,318 % |
Unternehmenskontakt
Autolus Therapeutics Plc
The Mediaworks 191 Wood Lane
W12 7FP, London
+44 20 3829 6230
http://www.autolus.comSektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-1.55% | 1.66 Mrd. | |
+3.01% | 108 Mrd. | |
+9.30% | 104 Mrd. | |
+6.20% | 23.66 Mrd. | |
-11.64% | 22.1 Mrd. | |
-3.29% | 19.71 Mrd. | |
-35.98% | 18.2 Mrd. | |
-13.26% | 16.19 Mrd. | |
+4.68% | 13.72 Mrd. | |
+34.94% | 12.22 Mrd. |
- Börse
- Aktien
- Aktie Autolus Therapeutics plc - Nasdaq
- Unternehmen Autolus Therapeutics plc